Arkolith/Insider Trading/AADI/Form 4

Desai Neil

Executive Chairman, Director, 10% OwnerAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed May 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$306K
Net Open-Market Flow
-$306K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 3, 2023Sell(S)8K$7.68$59K1.8M
May 2, 2023Sell(S)8K$7.48$56K1.8M
May 1, 2023Sell(S)24K$7.80$191K1.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-027161) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML